Navigation Links
Johns Hopkins neuroscientists win National Academy of Science Awards
Date:1/14/2013

Solomon H. Snyder, M.D., has won the National Academy of Sciences (NAS) Award in Neurosciences, and King-Wai Yau, Ph.D., has won the Alexander Hollaender Award in Biophysics, the NAS has announced. Both of these prestigious awards are offered only once every three years. Snyder and Yau will receive the awards on Sunday, April 28, during the Academy's 150th annual meeting.

"We are very proud to have two of our neuroscience faculty win awards from NAS in the same year," says Richard Huganir, Ph.D., director of the Solomon H. Snyder Department of Neuroscience. "Sol has contributed more to the field of molecular neuroscience than anyone in the world and is one of the luminaries in the field, and King's rigorous physiological and molecular approach has made him the preeminent biophysicist in vision research."

Snyder, a professor of neuroscience and former director of the eponymous Solomon H. Snyder Department of Neuroscience at the Institute for Basic Biomedical Sciences at the Johns Hopkins University School of Medicine, was recognized for groundbreaking discoveries ranging from the discovery of opiate receptors in the brain to proof that gases such as nitric oxide can serve as messengers between neurons. Many advances in molecular neuroscience have stemmed from Snyder's identification of receptors that neurons have for messenger molecules and some medications, a find which led to clarification of how these drugs work in the brain. His award comes with a $25,000 cash prize.

Yau, a professor of neuroscience and ophthalmology, was recognized for his work on vision. He discovered that two signaling molecules, calcium and cyclic GMP, convert light into electrical signals in the retina's rod and cone photoreceptor cells. This work led to a greater understanding of hereditary blinding diseases that affect rod and cone cells. By characterizing the light-response behaviors of a new type of photoreceptor cell in the retina, Yau found these cells a
'/>"/>

Contact: Vanessa McMains
vmcmain1@jhmi.edu
410-502-9410
Johns Hopkins Medicine
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. US Drug Watchdog Now Urges Families Of Diabetics Diagnosed with Bladder Cancer To Call The Johnson Law Group If They Used the Diabetes Drug Called Actos
2. US Drug Watchdog Now Urges Users of Yaz or Yasmin Birth Control Pills Who Suffered A Life Threatening Medical Problem To Call The Johnson Law Group-Immediately
3. US Drug Watchdog Now Urges Family Members Mourning The Loss Of A Loved One Who Developed Bladder Cancer After Using The Diabetes Drug Actos To Call The Johnson Law Group
4. The US Drug Watchdog Now Urges Users Of The Birth Control Pills Yaz-Yasmin to Contact The Johnson Law Group For a Legal Review if They Developed Severe Medical Problems
5. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
6. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
7. US Drug Watchdog Is Expanding Their Yaz-Yasmin Birth Control Pill Initiative and They Urge Victims to Contact the Johnson Law Group if They Had a Heart Attack or Stroke
8. Johns Hopkins receives funding for cholera vaccine initiative
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. A Serious Problem: Medical Malpractice Lawyers at Console & Hollawell React to Alarming Doctor Error Statistics from Johns Hopkins University Researchers
11. US Drug Watchdog Now Fears Most Women Never Heard About Yaz or Yasmin Birth Control Pill Side Effects and They Urge to Victims to Call the Johnson Law Group-Get Help Now
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Johns Hopkins neuroscientists win National Academy of Science Awards
(Date:9/23/2014)... September 23, 2014 Rinovum Women’s Health ... assistance device on the market cleared by the FDA ... and online at http://www.storkotc.com . , For the ... having a baby is delayed by infertility1 or other ... to optimize their chances to conceive. It is ...
(Date:9/23/2014)... September 23, 2014 AltMed ... to the development and production of medical cannabis ... Vida Cannabis . , The two ... technical expertise. They’ll also pool business development ... respective markets. , "We’re deeply impressed with the ...
(Date:9/23/2014)... of Cambridge has found that a common characteristic of autism ... in the brain. The results are published today (23 September) ... researchers studied 80 adult men with autism: 38 who had ... that language delay was associated with differences in brain volume ... insula, ventral basal ganglia, which were all smaller in those ...
(Date:9/23/2014)... 23, 2014 WetKeys Washable Keyboards announces ... in their industrial keyboards line. Labeled ... to last longer in heavy-duty industrial computing for the ... where grease and oil can destroy usability or cause ... constant threat to the longevity of computer equipment and ...
(Date:9/23/2014)... France (PRWEB) September 23, 2014 Névo ... designing a precision timepiece and adding advanced activity tracking ... that continuously monitors steps, distance, calories burned, and more. ... the need to adopt healthy habits in their busy ... to quantify small changes that produce healthy results, but ...
Breaking Medicine News(10 mins):Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4Health News:Florida Medical Cannabis Leader AltMed Allies With Canada's Vida Cannabis To Build Best-in-Class Expertise 2Health News:Florida Medical Cannabis Leader AltMed Allies With Canada's Vida Cannabis To Build Best-in-Class Expertise 3Health News:Presence or absence of early language delay alters anatomy of the brain in autism 2Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 2Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 3Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 4Health News:WetKeys Announces New Oil Resistant Keyboard for Industrial Computing, Food Processing Plants, Automotive Factories and Machine Shops 5Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 2Health News:Nevo changes the face of fitness wearables with an analogue watch combining activity tracking, phone notifications, and LED goal progress indicators for active lifestyles 3
... so many problems in our health care delivery,system and ... are having problems getting care as well as paying ... Health & Science University,family physician. The study, "Insurance Plus ... Health Care Access for Low Income,Families," recently was published ...
... in the world over 300 families are being recruited ... the treatment of childhood eczema. , The independent trial ... received funding of nearly 1million from the Department of ... Assessment (HTA) programme. The study will focus on hard ...
... a CT scan, and the masses look benign, they ... recent study conducted by researchers at Brown University in ... CT, we are frequently encountering findings that are not ... called incidentalomas, of which adrenal masses are quite common, ...
... to Evaluate Ultra-Pure Ethyl EPA-Niacin ... Treatment of Niacin- Induced Flushing, LONDON, November 29 ... has commenced a phase I clinical,safety and efficacy trial in ... and niacin on niacin induced,flushing. Flushing is a common side ...
... 29 Diabetes Response,Service, the first and only ... and Canada December 1st, 2007 providing scheduled,daily phone ... subscribers to,prevent hypoglycemia and complications such as seizures, ... provides customizable,scheduled text message reminders to help manage ...
... Nov. 29 As part of its HIV,Testing ... for,leading experts on HIV/AIDS issues including HIV screening, ... women., In September 2006, Centers for Disease ... screening that called for,voluntary opt-out screening to be ...
Cached Medicine News:Health News:New study shows low-income families face 3 barriers to health care 2Health News:New study shows low-income families face 3 barriers to health care 3Health News:Eczema sufferers test out benefits of water softeners 2Health News:Eczema sufferers test out benefits of water softeners 3Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 2Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 3Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 4Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 5Health News:Diabetes Response Service Launches in U.S. and Canada 2Health News:Experts Available to Discuss World AIDS Day, HIV/AIDS Issues Facing America 2
(Date:9/22/2014)... Sept. 22, 2014  For many people experiencing ... means facing the prospect of large, painful incisions ... regular activities are also impacted, such as working, ... of the problem, some patients even delay necessary ... even lead to permanent damage for some conditions. ...
(Date:9/22/2014)... PLYMOUTH MEETING, Pa. , Sept. 22, 2014 ... ) announced today it has initiated a phase ... The trial will evaluate the safety, tolerability, and ... type 6 (HPV-6), which causes most aerodigestive cancers. ... tongue, nose, throat, vocal cords, and parts of ...
(Date:9/22/2014)... 2014  CorMedix Inc. (NYSE MKT: CRMD), a ... products for the prevention and treatment of cardiorenal ... that TUV-SUD and The Medicinal Evaluation Board of ... granted its request for a label expansion for ... approved in July 2013 for use in the ...
Breaking Medicine Technology:Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3
... May 26, 2011 Rigel Pharmaceuticals, Inc. ... of its previously announced underwritten public offering of 16,300,000 ... of $8.00 per share to the public. The gross ... be approximately $130,400,000, before deducting underwriting discounts and commissions, ...
... Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP ) ... amount of senior unsecured notes. The notes will be unsecured, ... certain of the Company,s subsidiaries.   Endo intends ... cash on hand and borrowings under its new credit facility, ...
Cached Medicine Technology:Rigel Announces Pricing of Public Offering of Common Stock 2Rigel Announces Pricing of Public Offering of Common Stock 3Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes 2
... ENA Multiparameter Kit is designed ... six of the most common ... unique quality control system. The ... well in each strip gives ...
Inquire...
Microalbumin Linearity Control...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Medicine Products: